Lupin Ltd

NSE: LUPIN · BSE: 500257 · Pharmaceuticals & Biotechnology · 57 announcements

Lupin Ltd news stories on ALFA NewsRead the news →

Share price: ₹2,006.90
Market cap: ₹91,774 Cr
Revenue (annual): ₹27,958 Cr
Net profit (annual): ₹5,333 Cr
P/E (TTM): 16.6×Sector 47.4×
Promoter holding: 46.85%-0.01% QoQ
FII holding: 22.42%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

8 May 2026 00:10 IST NSE

Lupin Board Meeting Outcome

Lupin recommended appointing Deloitte Haskins & Sells as Statutory Auditors for five years. This follows the tenure completion of current auditors B S R & Co. LLP.

Execution: 60 months

Read the filing ↗